Charles R Drew University of Medicine and Science, College of Medicine Internal Medicine

Topics

• Dialysis and Renal Disease Management 395
• Diabetes Treatment and Management 208
• Diabetes Management and Research 97
• Parathyroid Disorders and Treatments 94
• Thyroid Disorders and Treatments 89
• Chronic Kidney Disease and Diabetes 61
• Diabetes, Cardiovascular Risks, and Lipoproteins 57
• Acute Ischemic Stroke Management 54
• Palliative Care and End-of-Life Issues 42
• Diet and metabolism studies 39
• Nutrition and Health in Aging 38
• Biotechnology and Related Fields 37

Most cited

1. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.

   Thyroid : official journal of the American Thyroid Association · 2025 · 499 citations · Gregory Brent

2. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association.

   Stroke · 2026 · 184 citations · Nestor Gonzalez

3. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

   The New England journal of medicine · 2021 · 1,567 citations · Juan Frias

4. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

   The New England journal of medicine · 2023 · 858 citations · Juan Frias

5. Chronic kidney disease.

   Lancet (London, England) · 2021 · 1,112 citations · Kamyar Kalantar-Zadeh

6. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

   Lancet (London, England) · 2023 · 644 citations · Juan Frias